Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

VIA Pharmaceuticals Inc

+ Add to Watchlist


0.0065 USD 0.0004 6.56%

As of 20:10:03 ET on 04/28/2015.

Snapshot for VIA Pharmaceuticals Inc (VIAP)

Open: 0.0065 Day's Range: 0.0065 - 0.0065 Volume: 2,680
Previous Close: 0.0061 52wk Range: 0.0053 - 0.0489 1-Yr Rtn: -78.33%

Stock Chart for VIAP

No chart data available.
  • VIAP:US 0.0065
  • 1D
  • 1M
  • 1Y
Interactive VIAP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VIAP

Current P/E Ratio (ttm) -
Estimated P/E(12/2011) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4600
Est. EPS (USD) (12/2011) -
Est. PEG Ratio -
Market Cap (M USD) 0.13
Shares Outstanding (M) 20.56
30 Day Average Volume 879
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VIAP

No data available

Company Profile & Key Executives for VIAP

VIA Pharmaceuticals Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. The Company is developing a pipeline of small-molecule drugs that target inflammation in the blood vessel wall, an underlying cause of atherosclerosis and its complications, including heart attack and stroke.

Douglass B GivenChairmanLawrence K CohenPresident/CEO
Rebecca A TaubSenior VP:Research & DevKaren S WrightVP/Controller
More Company Profile & Key Executives for VIAP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil